HEALTH OF WOMAN. 2017.2(118):111–117; doi 10.15574/HW.2017.118.111

 Veropotvelyan P. M., Tsekhmistrenko I. C., Chuvakov A. N., Pivnev M. C., Pivnevа N. V.
Interregional center of medical genetics and prenatal diagnosis, Krivoy Rog
Perinatal center, Kiev
The medical diagnostic center, Krivoy Rog
MI «Kryvyi Rih city clinical hospital №1» DRC»
Center of family planning and human reproduction, Krivoy Rog

Kliniko-epidemiological these papillomas virus and herpes – a viral infection, in particular about genital herpes – one of the most widespread viral infections are presented in article.

Key words: virus of papilloma of the person, cancer of a neck of uterus, persistention, reinfection, carriage of virus, immunomodulators, herpesviridae infection, genital herp, interferon inductors.

REFERENCES

1. Kalugina LV. 2013. VPCh i patologiya reproduktivnoy sistemyi. DU «Institut pediatrii, akusherstva i ginekologii NAMNU». K.

2. Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines. 2006. MMWR Rceomm. Rep. 2006. 55(RR-11): 62–7.

3. De Vuyst H, Clifford GM, Nascimento MC, Madeleine MM, Franceschi S. 2009. Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus: a meta-analysis. Int. J. Cancer. 124(7): 1626–36. https://doi.org/10.1002/ijc.24116

4. Russomano F, Reis A, de Camargo MJ, Dutra MV, Fonseca SC, Anderson J. 2000. Efficacy in treatment of subclinical cervical HPV infection without intraepithelial neoplasia: systematic review. San Paulo Med. J. 118(4): 109–15. https://doi.org/10.1590/S1516-31802000000400007; PMid:10887387

5. Smith MA, Canfell K, Brotherton JML, Lew J-B, Barnabas RV. 2008. The predicted impact of vaccination on human papillomavirus infections in Australia. Int. J. Cancer. 123(8): 1854–63. https://doi.org/10.1002/ijc.23633; PMid:18636563

6. Lobato S, Tafuri A, Fernandes PA, Caliari МV, Silva MX, Xavier MA, Vago AR. 2012. Minichromosome maintenance 7 protein is a reliable biological marker for human cervical progressive disease. J. Gynecol. Oncol. 23(1): 11–5.

7. Garland SМ, Insinga RP, Sings HL, Haupt RM, Joura EA. 2009. Human papillomavirus infections and vulvar disease development. Cancer Epidemiol. Biomarkers Prev. 18(6): 1777–84. https://doi.org/10.1158/1055-9965.EPI-09-0067; PMid:19505910

8. Brown CA, Bogers J, Sahebali S, Depuydt CE, De Prim F, Malinowski DP. 2012. Role of protein biomarkers in the detection of high– grade disease in cervical cancer screening programs. J. Oncol. 2012: 289315. https://doi.org/10.1155/2012/289315; PMid:22481919 PMCid:PMC3317214

9. Batkaev EA. 2013. Genital herpes. Journal of Postgraduate Medical Education. 3: 20–3.

10. Levin AE, Samoutine FL. 1998. Neovir monotherapy in chronic recurrent genital herpes. Diseases transmitted through sexual contact. 1: 18–21.

11. Meeting of the Strategic Advisory Group of Experts on immunization, April 2014 – conclusions and recommendations. Wkly Epidemiol. Rec. 2014. 89(21): 221–36.

12. Prilepskaya VN, Nazarova NM, Mzarelua GM, Fazullin LZ, Trofimov DYu. 2015. HPV-associated cervical disease – new in diagnostics. Obstetrics and Gynecology 9: 20–26.

13. Workowski KA, Berman S. 2010. Centers for Disease Control and Prevention (CDC). Sexually transmitted diseases treatment guidelines, 2010. MMWR Recomm. Rep. 59(RR-12): 1–110.

14. Zhao Y, Cao X, Zheng Y. 2012. Relationship between cervical disease and infection with human papillomavirus types 16 and 18, and herpes simplex virus 1 and 2. J Med Virol. 4;12:1920–1927. https://doi.org/10.1002/jmv.23353; PMid:23080497

15. Brown DR, Shew ML, Oadadri B, Neptune N, Vargas М, Tu W et al. 2005. A longitudinal study of genital human papillomavirus infection in a cohort of closely followed adolescent women. J. Infect. Dis. 191(2): 182–92.

16. Tornesello ML, Duraturo ML, Losito S, Botti G, Pilotti S, Stefanon B et al. 2008. Human papillomavirus genotypes and HPV16 variants in penile carcinoma. Int. J. Cancer. 122(1): 132–7.

17. Robinson D, Coupland V, Mailer H. 2009. An analysis of temporal and generational trends in the incidence of anal and other HPV-related cancers in Southeast England. Br. J. Cancеr. 100(3): 527–31. https://doi.org/10.1038/sj.bjc.6604871

18. Shukla S, Bharti AC, Mahata S, Hussain S, Kumar R, Hedau S, Das BC. 2009. Infection of human papillomaviruses in cancers of different human organ sites. Indian J. Med. Res. 130(3): 222–33.

19. Grm HS, Bergant M, Banks L. 2009. Human papillomavirus infection, cancer and therapy. Indian J. Med. Res. 130(3): 277–85.

20. Hsueh PR. 2009. Human papillomavirus, genital warts, and vaccines. J. Microbiol. Immunol. Infect. 42(2): 101–6.

21. Palefsky JM, Cranston RD, Dezube BJ, Ross ME. 2012. Anal intraepithelial neoplasia: diagnosis, screening, prevention, and treatment. Ct. opubl. na UpToDate onlajn (konsul’tativnyj med. forum v SShA).

22. Schiffman М, Castle PE, Jeronimo J, Rodriguez AC, Wacholder S. 2007. Human papillomavirus and cervical cancer. Lancet. 370(9590): 890–907.

23. Dyson S, Pitts М, Lyons A, Mullins R. 2010. Providing high quality information about human papillomavirus for women after treatment for high-grade cervical dysplasia. Sex. Health. 7(1): 49–54.

24. Pepas L, Kaushik S, Bryant A, Nordin A, Dickinson HО. 2011. Medical interventions for high grade vulval intraepithelial neoplasia. Cochrane Database Syst. Rev. 4.

25. Wang HK, Duffy AA, Broker TR, Chow LT. 2009. Robust production and passaging of infectious HPV in squamous epithelium of primary human keratinocytes. Genes Dev. 23(2):181–94. https://doi.org/10.1101/gad.1735109; PMid:19131434 PMCid:PMC2648537

26. Massad LS, Einstein MH, Huh WK, Katki HA, Kinney WK, Schiffman M et al. 2013. 2012 ASCCP Consensus Guidelines Conference. 2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors. Obstet. Gynecol. 121(4): 829–46.

27. Wang X, Wang H-K, Li Y. 2014. microRNAs are biomarkers of oncogenic human papillomavirus infections. Proc. Natl. Acad. Sci. USA. 111(11): 4262–7.

28. Scheffner M, Werness BA, Huibregtse JM, Levine AJ, Howley PM. 1990. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell. 63(6): 1129–36. https://doi.org/10.1016/0092-8674(90)90409-8

29. Roman A, Munger K. 2013. The papillomavirus E7 proteins. Virology. 445(1-2): 138–68.

30. Hryanin AA, Reshetnikov OV. 2015. Inductors interferon in the treatment of genital herpes in women. Obstetrics and Gynecology 7: 88–89.

31. Weiss H. 2004. Epidemiology of herpes simplex virus type 2 infection in the developing world. Herpes. 11(Suppl. 1): 24A–35A.

32. Nandakumar S, Woolard SN, Yuan D, Rouse BT, Kumaraguru U. 2008, Nov. Natural killer cells as novel helpers in anti-herpes simplex virus immune response. Journal of virology 82(21).

33. Dovlethanova ER, Prilepskaya VN. 2015. A differentiated approach to the treatment of genital disease in women associated with HPV infection. Obstetrics and Gynecology 10: 118–124.

34. Rogovskaya NY, Bebneva TN, Nekrasov PI, Polonskaya NY. 2014. Efficiency of treatment of diseases of the genitals with a combination of human papillomavirus and herpes virus infection. Obstetrics and Gynecology 9: 90–97.

35. Beauman JG. 2005. Genital herpes: a review. Am. Fam. Physician. 72(8): 1527–34.

36. Bauer G. 2002. The color atlas on кольпоскопии / the Lane with him. O.A. Zubanova; under the editorship of S.I. Rogovskaya. M, GEOTAR – HONEY.

37. Danilov EV. 2014. Influence of a human papillomavirus infection on the course of pregnancy. «EFFECTIVE PHARMACOTHERAPY. Obstetrics and gynecology. Special issue 38.

38. Protasova AE, Dzyuby TI, Raskin GA, Tapilskaya NI, Zazerskaya IE, Hadzhiyeva ED. 2014. Displaziya of a uterus neck – этиопатогенез, diagnostics, optimum tactics of treatment. Manual. SPb:22.